NextCure, Inc. Quarterly Operating Income (Loss) in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
NextCure, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2018 to Q3 2024.
  • NextCure, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$12.5M, a 20% increase year-over-year.
  • NextCure, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$63.1M, a 9.39% increase year-over-year.
  • NextCure, Inc. annual Operating Income (Loss) for 2023 was -$67.6M, a 10.9% increase from 2022.
  • NextCure, Inc. annual Operating Income (Loss) for 2022 was -$75.9M, a 7.27% decline from 2021.
  • NextCure, Inc. annual Operating Income (Loss) for 2021 was -$70.8M, a 71.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$63.1M -$12.5M +$3.12M +20% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$66.2M -$16.5M +$2.66M +13.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 -$68.9M -$18.3M -$1.23M -7.22% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$67.6M -$15.8M +$1.98M +11.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$69.6M -$15.6M +$3.62M +18.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$73.2M -$19.2M -$1.03M -5.68% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$72.2M -$17.1M +$3.7M +17.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$75.9M -$17.8M -$700K -4.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$75.2M -$19.2M -$731K -3.95% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$74.5M -$18.1M -$176K -0.98% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$74.3M -$20.8M -$3.54M -20.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$70.8M -$17.1M -$834K -5.14% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 -$69.9M -$18.5M -$1.11M -6.37% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$68.8M -$18M -$2.15M -13.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$66.7M -$17.2M -$25.4M -310% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$41.2M -$16.2M -$4.23M -35.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-03
Q3 2020 -$37M -$17.4M -$7.7M -79.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$29.3M -$15.8M -$6.85M -76.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$22.5M $8.21M +$15M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$37.5M -$12M -$4.94M -69.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 -$32.5M -$9.7M -$3.88M -66.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$28.7M -$8.96M -$3.66M -69% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$25M -$6.82M -$1.81M -36.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$23.2M -$7.07M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$5.82M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$5.3M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 -$5.01M Jan 1, 2018 Mar 31, 2018 10-Q 2019-06-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.